Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
---|
03/05/2008 | CN101134755A Quinazoline(di) ones for invertebrate pest control |
03/05/2008 | CN100372825C 3,4-difluoro-2-methoxyl biphenyl derivative and its preparation process and application |
03/04/2008 | US7338978 Insecticidal anthranilamides |
03/04/2008 | US7338959 N2-isopropyl-N5,1-dimethyl-N5-[2-({4-[(methylsulfonyl)methyl]phenyl}amino)pyrimidin-4-yl]-1H-benzimidazole-2,5-diamine; vascular endothelial growth factor (VEGF) receptor-2 and tyrosine kinase containing Ig and EGF homology domains (TIE) -2 inhibitor; antiproliferation and antihypoxic agent |
03/04/2008 | US7338958 Sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents |
02/28/2008 | WO2008024634A1 Pyrimdine compounds useful as kinase inhibitors |
02/28/2008 | WO2008023357A1 Heterocyclic derivatives binding to the peripheral-type benzodiazepine receptor (pbr) |
02/28/2008 | WO2008023180A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
02/28/2008 | WO2008023159A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
02/28/2008 | US20080051424 Heterocyclyl-substituted nonadepsipeptides |
02/28/2008 | US20080051412 Stereoisomerically Enriched 3-Aminocarbonyl Bicycloheptene Pyrimidinediamine Compounds and their Uses |
02/28/2008 | US20080051404 Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
02/28/2008 | US20080051401 2,4,6-Trisubstituted Pyrimidines as Phosphotidylinositol (Pi) 3-Kinase Inhibitors and Their Use in the Treatment of Cancer |
02/28/2008 | US20080051399 Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors |
02/28/2008 | US20080051395 2-Pyrimidinyl Pyrazolopyridine Erbb Kinase Inhibitors |
02/28/2008 | US20080051384 Antiviral agents |
02/28/2008 | CA2661307A1 Heterocyclic derivatives binding to the peripheral-type benzodiazepine receptor (pbr) |
02/28/2008 | CA2661223A1 4-aminoquinazoline derivatives and methods of use thereof |
02/27/2008 | EP1892245A2 Antineoplastic compounds and pharmaceutical compositions thereof |
02/27/2008 | EP1891021A1 Aspartyl protease inhibitors |
02/27/2008 | EP1891020A2 Processes for the preparation of azoxystrobin using dabco as a catalyst and novel intermediates used in the processes |
02/27/2008 | EP1891019A2 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists |
02/27/2008 | EP1891018A2 Modulators of atp-binding cassette transporters |
02/27/2008 | EP1890703A2 Pyrimidine compounds |
02/27/2008 | EP1890697A2 Azinone and diazinone v3 inhibitors for depression and stress disorders |
02/27/2008 | EP1789014B1 Substance for dyeing keratinic fibers |
02/27/2008 | EP1446115B1 Cyanoalkylamino derivatives as protease inhibitors |
02/27/2008 | EP1248612B1 Novel compounds and compositions as protease inhibitors |
02/27/2008 | CN101133038A HIV inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines |
02/27/2008 | CN101130542A Synthesis method of antiviral nucleoside analogue |
02/27/2008 | CN101130521A Novel pyrimidine derivative with obvious biological activity |
02/27/2008 | CN100371329C Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases |
02/27/2008 | CN100371318C Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
02/27/2008 | CN100370975C Inhibitors against the production and releaseof inflammator cytokines |
02/27/2008 | CA2660758A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
02/26/2008 | US7335672 Vanilloid receptor ligands and their use in treatments |
02/26/2008 | US7335663 Heteroaryl compounds which inhibit leukocyte adhesion mediated by α4 integrins |
02/26/2008 | US7335662 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 4-(4-pyrimid-2-ylaminosulfonyl-1,4-phenylene-aminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole |
02/26/2008 | US7335659 Substituted 10-aryl-11H-benzo[b]fluorenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
02/26/2008 | US7335657 Cytokine inhibitors |
02/21/2008 | WO2008020711A1 Quinazoline derivative as phosphodiesterase inhibitor and a process for preparing the same |
02/21/2008 | WO2008020425A1 Crystalline moxonidine comprising single tautomer and preparation process therefor |
02/21/2008 | WO2007146981A3 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha |
02/21/2008 | WO2007103456A3 Piperazine and piperidine biaryl derivatives |
02/21/2008 | WO2007010222A3 Therapeutic agents |
02/21/2008 | US20080045712 Process for Preparing 4-Aminopyrimidine Compound |
02/21/2008 | US20080045710 Chemotherapeutic compounds for selectively targeting tumor cells with FR type receptors |
02/21/2008 | US20080045555 hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors; avoiding adverse effects such as hepatotoxicity and cutaneous flushing; low dosage; 2-bromo-8-methyl-4-pentyl-1,4-dihydro-5H-[1,2,4]triazolo[5,1-i]purin-5-one; to treat cardiovascular disorders |
02/21/2008 | US20080045554 hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors; avoiding adverse effects such as hepatotoxicity and cutaneous flushing; low dosage; 2-bromo-8-methyl-4-pentyl-1,4-dihydro-5H-[1,2,4]triazolo[5,1-i]purin-5-one; to treat cardiovascular disorders |
02/21/2008 | US20080045550 [1-(4-chloro-3-ethoxy-benzyl)-piperidin-4-yl]-(2-chloro-pyrimidin-4-yl)-amine; somatostatin receptor subtype 5 (SSTR5) antagonists; diabetes mellitus |
02/21/2008 | US20080045546 Tetradydro-Naphthalene And Urea Derivatives |
02/21/2008 | US20080045535 Prokineticin 2 receptor antagonists |
02/21/2008 | US20080045529 Use Of Thienopyrimidines |
02/21/2008 | US20080045517 Such as {(2S)-2-[2-[2-(7-azabicyclo[2.2.1]hept-7-yl)-1,1-dimethyl-2-oxoethyl]-5-(3,5-dimethylphenyl)-6H-thieno[2,3-b]pyrrol-4-yl]propyl}(2-pyridin-4-ylethyl)amine for treating sex hormone related prostate cancer and pre-menopausal breast cancer |
02/21/2008 | US20080045516 Viral Polymerase Inhibitors |
02/21/2008 | US20080045500 Nerve Regeneration Stimulator |
02/21/2008 | US20080044379 (1R)-2-((2S)-2-(5-(6-(4-(2-((2S)-1-((2R)-2-(dimethylamino)-2-phenylacetyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)phenyl)-3-pyridinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl) -N,N-dimethyl-2-oxo-1-phenylethanamine; inhibit the function of the non-structural proteins (NS5A) |
02/21/2008 | CA2660659A1 Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects |
02/21/2008 | CA2658843A1 Crystalline antifungal compounds |
02/20/2008 | EP1889845A1 Novel pleuromutilin derivatives |
02/20/2008 | EP1889836A1 Novel pyridine derivative and pyrimidine derivative (3) |
02/20/2008 | EP1888538A1 (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-ht receptor |
02/20/2008 | EP1888537A1 Process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino benzonitrile |
02/20/2008 | EP1888536A1 Method for preparing substituted pyrimidines |
02/20/2008 | EP1888535A1 New heterocyclylethylbenzamide derivatives |
02/20/2008 | EP1888534A2 Organic compounds |
02/20/2008 | EP1888518A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor |
02/20/2008 | EP1888509A1 Benzoyl-substituted serine amides |
02/20/2008 | EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
02/20/2008 | EP1289968B1 Cyclic urea compounds and preparation thereof |
02/20/2008 | CN101128441A Fused aromatic compounds having anti-diabetic activity |
02/20/2008 | CN101128438A Substituted 1,1,1-trifluoro-3-[(benzyl)-(pyrimidin-2-yl)-amino]-prop an-2-ol compounds |
02/20/2008 | CN101128437A Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof |
02/20/2008 | CN101128436A 甘氨酸衍生物及其用途 Glycine derivatives and their use |
02/20/2008 | CN101128199A Monocyclic heterocycles as kinase inhibitors |
02/20/2008 | CN101125138A Inhibitors against the production and release of inflammatory cytokines |
02/20/2008 | CN100369888C N-alkanoylphenylalanine derivatives |
02/19/2008 | US7332514 Dibenzylamine compound and medicinal use thereof |
02/19/2008 | US7332511 Vanilloid receptor ligands and their use in treatments |
02/19/2008 | US7332509 Used for controlling animal pests, in particular arthropods, such as insects and acarids, and helminths |
02/19/2008 | US7332499 N-[(1R)-1-(2-fluoro-4-{1-[(trifluoromethyl)sulfonyl]-1,2,3,4-tetrahydroquinolin-8-yl}phenyl)ethyl]-1-[(trifluoroacetyl)amino]cyclopropanecarboxamide; bradykinin B1 antagonists or inverse agonists; analgesic and antiinflammatory agent; acute and chronic pain |
02/19/2008 | US7332493 [3-Methyl-4-(pyridin-3-yloxy)-phenyl]-(6-piperidin-3-ylethynyl-quinazolin-4-yl)-amine; selective inhibitors of receptor tyrosine kinases and non-receptor tyrosine kinases (eg: Ick, src, abl) or serine/threonine kinases (e.g.: cyclin dependent kinases); carcinoma |
02/19/2008 | US7332487 Nitrogen-containing 5-membered ring compound |
02/19/2008 | US7332485 Peptide deformylase inhibitors |
02/19/2008 | US7332484 2,4-pyrimidinediamine compounds and their uses |
02/19/2008 | US7332483 3-(5-benzamido-2-chlorophenyl)-7-methoxy-3,4-dihydroquinazolin-4-one;cytokines (tumor necrosis factor and interleukins) inhibitor; antiinflammatory agent, rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease |
02/19/2008 | CA2328927C Benzamide derivatives for the treatment of diseases mediated by cytokines |
02/19/2008 | CA2207100C Pyrimidine derivatives |
02/19/2008 | CA2206366C Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
02/14/2008 | WO2008019124A1 Heteroaryl compounds useful as inhibitors of e1 activating enzymes |
02/14/2008 | WO2008018544A1 Sulfonamide compound or salt thereof |
02/14/2008 | WO2008018306A1 Quinazoline derivative |
02/14/2008 | WO2007018248A9 Pyridone compound |
02/14/2008 | US20080039622 2,4-pyrimidinediamine compounds and their uses |
02/14/2008 | US20080039480 Quinazolinedione Derivatives as Parp Inhibitors |
02/14/2008 | US20080039479 Compounds and therapeutical use thereof |
02/14/2008 | US20080039458 Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine |
02/14/2008 | US20080039447 CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents |
02/14/2008 | US20080039446 Substituted isoindoles and their use |
02/14/2008 | CA2660424A1 Sulfonamide compound or salt thereof |